Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: A systematic review and meta-analysis

A Meggiolaro, M Sane Schepisi, S Farina… - Expert Review of …, 2022 - Taylor & Francis
Background This meta-analysis aims to assess the effectiveness of the current Sars-Cov2
vaccine regimens against Omicron infection. A secondary endpoint aims to investigate the …
被引用次数：18 相关文章
[HTML] europepmc.org

[HTML][HTML] Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalisation: a systematic review and meta-analysis

A Meggiolaro, MS Schepisi, S Farina, C Castagna… - 2022 - europepmc.org
Background The rapid rise of Sars-Cov2 B. 1.1. 529 variant (named Omicron) in the late
November 2021 prompted the health authorities to estimate the potential impact on the …

Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis

A Meggiolaro, MS Schepisi, S Farina… - Expert review of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background This meta-analysis aims to assess the effectiveness of the current Sars-Cov2
vaccine regimens against Omicron infection. A secondary endpoint aims to investigate the …

Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalisation: a systematic review and meta-analysis

A Meggiolaro, MS Schepisi, S Farina, C Castagna… - medRxiv, 2022 - medrxiv.org
Background The rapid rise of Sars-Cov2 B. 1.1. 529 variant (named Omicron) in the late
November 2021 prompted the health authorities to estimate the potential impact on the …
[PDF] core.ac.uk

[PDF][PDF] Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis

A Meggiolaro, MS Schepisi, S Farina… - EXPERT REVIEW OF …, 2022 - core.ac.uk
Background: This meta-analysis aims to assess the effectiveness of the current Sars-Cov2
vaccine regimens against Omicron infection. A secondary endpoint aims to investigate the …
[PDF] archive.org

[PDF][PDF] page· Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease

A Siddu, P Stefanelli, S Boccia, G Rezza - scholar.archive.org
Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic
disease, and hospitalisation: a systemati Page 1 1 Title page· Effectiveness of vaccination …

Effectiveness of vaccination against SARS-CoV-2 omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis.

A Meggiolaro, MS Schepisi, S Farina, C Castagna… - 2022 - cabidigitallibrary.org
Background This meta-analysis aims to assess the effectiveness of the current Sars-Cov2
vaccine regimens against Omicron infection. A secondary endpoint aims to investigate the …

Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis

A Meggiolaro, M Sane Schepisi, S Farina… - EXPERT REVIEW OF …, 2022 - iris.unisr.it
Background: This meta-analysis aims to assess the effectiveness of the current Sars-Cov2
vaccine regimens against Omicron infection. A secondary endpoint aims to investigate the …

Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis

A Meggiolaro, M Sane Schepisi, S Farina… - EXPERT REVIEW OF …, 2022 - publicatt.unicatt.it
Background This meta-analysis aims to assess the effectiveness of the current Sars-Cov2
vaccine regimens against Omicron infection. A secondary endpoint aims to investigate the …
[PDF] unisr.it

[PDF][PDF] Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis

A Meggiolaro, MS Schepisi, S Farina… - EXPERT REVIEW OF …, 2022 - iris.unisr.it
Background: This meta-analysis aims to assess the effectiveness of the current Sars-Cov2
vaccine regimens against Omicron infection. A secondary endpoint aims to investigate the …